We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

143 hedge funds and large institutions have $669M invested in Intellia Therapeutics in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

45% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 31

44% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 18

14% more capital invested

Capital invested by funds: $589M → $669M (+$80.7M)

5% more funds holding

Funds holding: 136 → 143 (+7)

3.1% more ownership

Funds ownership: 90.23% → 93.33% (+3.1%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

32% less call options, than puts

Call options by funds: $2.35M | Put options by funds: $3.46M

Holders
143
Holders Change
+7
Holders Change %
+5.15%
% of All Funds
2.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
45
Reduced
31
Closed
18
Calls
$2.35M
Puts
$3.46M
Net Calls
-$1.11M
Net Calls Change
-$2.66M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.6M
2
Citadel Advisors
Citadel Advisors
Florida
+$7.47M
3
N
Nuveen
North Carolina
+$6.28M
4
AIM
ARK Investment Management
Florida
+$3.77M
5
AG
Artal Group
Luxembourg
+$2.78M

Top Sellers

Rank Fund Capital Flow
1
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$10.7M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
-$3.54M
3
State Street
State Street
Massachusetts
-$1.85M
4
CS
Candriam SCA
Luxembourg
-$1.6M
5
UBS Group
UBS Group
Switzerland
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$1.78M +$131K +9,397 +8%
UBS Group
27
UBS Group
Switzerland
$1.68M -$1.54M -110,980 -49%
ROTUOC
28
Regents of the University of California
California
$1.64M – – –
Allianz Asset Management
29
Allianz Asset Management
Germany
$1.51M +$164K +11,794 +13%
3C
30
361 Capital
Colorado
$1.39M +$1.32M +94,772 New
Goldman Sachs
31
Goldman Sachs
New York
$1.37M -$823K -59,140 -39%
PP
32
PDT Partners
New York
$1.25M +$380K +27,317 +47%
Creative Planning
33
Creative Planning
Kansas
$1.23M +$5.58K +401 +0.5%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$1.07M -$35.1K -2,525 -3%
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$1.02M +$44.9K +3,229 +5%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$973K +$764K +54,900 +482%
PIM
37
Platinum Investment Management
Australia
$971K – – –
Swiss National Bank
38
Swiss National Bank
Switzerland
$961K +$76.5K +5,500 +9%
Citigroup
39
Citigroup
New York
$950K -$534K -38,396 -37%
EWM
40
Elmwood Wealth Management
California
$942K -$908K -65,235 -50%
Wells Fargo
41
Wells Fargo
California
$907K +$93K +6,684 +12%
California State Teachers Retirement System (CalSTRS)
42
California State Teachers Retirement System (CalSTRS)
California
$884K – – –
GIM
43
Granahan Investment Management
Massachusetts
$882K +$5.79K +416 +0.7%
AQR Capital Management
44
AQR Capital Management
Connecticut
$875K +$321K +23,099 +63%
Neuberger Berman Group
45
Neuberger Berman Group
New York
$864K -$9.67K -695 -1%
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$808K -$144K -10,335 -16%
TCM
47
Tekla Capital Management
Massachusetts
$808K – – –
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$801K – – –
OAM
49
Oxford Asset Management
United Kingdom
$798K +$256K +18,402 +51%
AllianceBernstein
50
AllianceBernstein
Tennessee
$786K – – –
1
2
3 4 5

NTLA Hedge Fund Activity: Q4 2019 in Review

143 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q4 2019, worth a combined $669M — up 14% from $589M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new NTLA positions and 18 closed out — a net gain of 8 holders — while 45 added to existing stakes and 31 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.6M. The largest seller was Ontario Teachers' Pension Plan Board, exiting entirely with an estimated $10.7M sold.

  • 143 institutional investors held Intellia Therapeutics (NTLA) as of Q4 2019, up from 136 in Q3 2019.
  • Funds reported $669M of Intellia Therapeutics stock for Q4 2019, up 14% quarter-over-quarter.
  • 26 funds opened new Intellia Therapeutics positions in Q4 2019 and 18 closed out, a net change of +8 holders.
  • The largest Intellia Therapeutics buyer in Q4 2019 was Fidelity Investments, an estimated $10.6M added.
  • The largest Intellia Therapeutics seller in Q4 2019 was Ontario Teachers' Pension Plan Board, an estimated $10.7M sold.

Based on aggregated 13F filings for Q4 2019.